Question follow-through · 16588
Breast Cancer: Drugs
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with AstraZeneca and Diiachi Sankyo on making Enhertu breast cancer drugs viable for introduction to the NHS.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 7 Jul 2026
- Target answer date
- 9 Jul 2026
- Answer
- 15 Jul 2026 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- CJD: Research · 8 Jul 2026
- Department of Health and Social Care: Public Expenditure · 13 Jul 2026
- Brain: Tumours · 28 Aug 2026
- Brain: Tumours · 28 Aug 2026
- Brain: Tumours · 28 Aug 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
7 Jul 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with AstraZeneca and Diiachi Sankyo on making Enhertu breast cancer drugs viable for introduction to the NHS.
9 Jul 2026
Target answer date
Date supplied by the official written-questions record.
15 Jul 2026
Answer published
I refer the hon. Member to the answer I gave to the hon. Member for South Basildon and East Thurrock on 29 June 2026 to Question 11564.
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
CJD: Research
8 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research to identify a cure for Creutzfeldt-Jakob disease.
Department of Health and Social Care: Public Expenditure
13 Jul 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 July 2026 to Question 15445 on Department of Health and Social Care: Public Expenditure, if she will set out which capital programmes have been identified as having fle
Brain: Tumours
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what funding her Department has allocated to research into low-grade glioma in each of the last five years.
Brain: Tumours
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, whether her Department plans to increase investment in research relating to low-grade glioma over the next spending period.
Brain: Tumours
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what estimate she has made of the annual NHS expenditure on the treatment and management of low-grade glioma patients in England.
Brain: Tumours
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that funding decisions for brain tumour research reflect the prevalence and clinical impact of low-grade glioma.
Brain: Tumours
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what assessment she has made of the availability of specialist treatment services for patients diagnosed with low-grade glioma across England.